Johnson & Johnson (JNJ) is expected to report its latest quarterly earnings on Tuesday before the stock market opens. The shares have been weak so far this month so let's review the condition of the charts to see if any bandages are needed.




Johnson & Johnson (JNJ) is expected to report its latest quarterly earnings on Tuesday before the stock market opens. The shares have been weak so far this month so let's review the condition of the charts to see if any bandages are needed.
As we say to goodbye to a rough September, let's look what what's weighing on investor sentiment now.
The identity security management firm gets a quantitative upgrade.
Not all the news from the small biotech space is bad. One company in particular already has been gaining the attention of investors.
We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.
Email Real Money's Wall Street Pros for further analysis and insight
Already a Subscriber? Login
Follow Real Money's Wall Street Pros to receive real-time investing alerts
Already a Subscriber? Login